{"version":"company-facts.v1","source":"https://secwatch.observer","generated_at":"2026-06-05T18:30:00.516521+00:00","company":{"ticker":"IRON","cik":1816736,"company_name":"Disc Medicine, Inc."},"pagination":{"limit":100,"returned":4,"next_cursor":null},"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer","facts":[{"fact_type":"earnings_release","fact_key":"5909e67c68b7d39d4b0588ef6f45a925f5685161","cik":1816736,"ticker":"IRON","company_name":"Disc Medicine, Inc.","filed_at":"2026-05-05T23:59:59+00:00","payload":{"eps_text":null,"guidance_signal":"none","item_codes_triggered":["2.02"],"net_income_text":"Net loss was $63.5 million for the three months ended March 31, 2026","period_text":"the first quarter ended March 31, 2026","report_date":"2026-05-05","result_type":"reported_results","revenue_text":null},"claim":"Disc Medicine, Inc. reported the first quarter ended March 31, 2026 results: net income Net loss was $63.5 million for the three months ended March 31, 2026.","evidence_excerpt":"On May 5, 2026, Disc Medicine, Inc. announced its financial results for the first quarter ended March 31, 2026 and provided a corporate update.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001193125-26-205187","anchor_url":"https://secwatch.observer/filing/0001193125-26-205187#claim-5909e67c68b7d39d4b0588ef6f45a925f5685161","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1816736/000119312526205187/0001193125-26-205187-index.htm"},{"fact_type":"restructuring_charge","fact_key":"81259e46f7f49ba9547a648780db648fe823a648","cik":1816736,"ticker":"IRON","company_name":"Disc Medicine, Inc.","filed_at":"2026-02-27T23:59:59+00:00","payload":{"affected_area":"commercial functions and certain supporting functions","charge_text":"approximately $2.0 million","effective_date":"2026-02-26","event_type":"restructuring","headcount_text":"approximately 20%","item_codes_triggered":["2.05"]},"claim":"Disc Medicine, Inc. announced a restructuring with charges of approximately $2.0 million affecting commercial functions and certain supporting functions (approximately 20%).","evidence_excerpt":"Company expects to complete the implementation of the Restructuring Plan in the second quarter of 2026. The Company expects that it will incur aggregate charges of approximately $2.0 million in connection with the Restructuring Plan, consisting primarily of severance costs, which will be recorded primarily in the first quarter of 2026. The costs that the Company","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001193125-26-082855","anchor_url":"https://secwatch.observer/filing/0001193125-26-082855#claim-81259e46f7f49ba9547a648780db648fe823a648","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1816736/000119312526082855/0001193125-26-082855-index.htm"},{"fact_type":"earnings_release","fact_key":"54d1a1d4e9bf0843b2645a6395df90e1e3c360c6","cik":1816736,"ticker":"IRON","company_name":"Disc Medicine, Inc.","filed_at":"2024-05-09T23:59:59+00:00","payload":{"eps_text":null,"guidance_signal":"none","item_codes_triggered":["2.02"],"net_income_text":"Net loss was $26.9 million","period_text":"the first quarter ended March 31, 2024","report_date":"2024-05-09","result_type":"reported_results","revenue_text":null},"claim":"Disc Medicine, Inc. reported the first quarter ended March 31, 2024 results: net income Net loss was $26.9 million.","evidence_excerpt":"Disc Medicine, Inc. announced its financial results for the quarter ended March 31, 2024 and provided a corporate update.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001193125-24-134796","anchor_url":"https://secwatch.observer/filing/0001193125-24-134796#claim-54d1a1d4e9bf0843b2645a6395df90e1e3c360c6","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1816736/000119312524134796/0001193125-24-134796-index.htm"},{"fact_type":"earnings_release","fact_key":"fa7dafe418b495a905e5024fb1a4d6432dc6cb10","cik":1816736,"ticker":"IRON","company_name":"Disc Medicine, Inc.","filed_at":"2024-03-21T23:59:59+00:00","payload":{"eps_text":null,"guidance_signal":"none","item_codes_triggered":["2.02"],"net_income_text":"Net loss was $76.4 million","period_text":"the fourth quarter and full year ended December 31, 2023","report_date":"2024-03-21","result_type":"reported_results","revenue_text":null},"claim":"Disc Medicine, Inc. reported the fourth quarter and full year ended December 31, 2023 results: net income Net loss was $76.4 million.","evidence_excerpt":"Disc Medicine, Inc. announced its financial results for the fourth quarter and fiscal year ended December 31, 2023","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001193125-24-073324","anchor_url":"https://secwatch.observer/filing/0001193125-24-073324#claim-fa7dafe418b495a905e5024fb1a4d6432dc6cb10","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1816736/000119312524073324/0001193125-24-073324-index.htm"}]}